Outcomes in acute ischemic stroke patients without angiographically documented arterial occlusion

Journal of Neuroimaging

Volumn 15, Issue 1, 2005, Pages 37-42

  Qureshi, Adnan I ^a,b,c   Kirmani, Jawad F ^b   Siddiqui, Amir M ^b   Hanel, Ricardo A ^a   Kim, Stanley H ^a   Hopkins, L Nelson ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c NEUROLOGICAL INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Intra arterial thrombolysis; Outcome; Thrombolyics

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN CIRCULATION; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONVALESCENCE; DISABILITY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; NEUROIMAGING; ONSET AGE; PONS; RATING SCALE; SYMPTOM; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; REGISTRIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 10644273629     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1177/1051228404270241     Document Type: Article

References (25)

1. Kassem-Moussa H, Graffagnino C. Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies. Arch Neurol 2002;59:1870-1873.
2. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11.
3. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
4. Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2094-2100.
5. Derex L, Tomsick TA, Brott TG, et al. The EMS Bridging Trial. Outcome of stroke patients without angiographically revealed arterial occlusion within four hours of symptom onset. Am J Neuroradiol 2001;22:685-690.
6. Qureshi AI, Siddiqui AM, Suri MFK, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002;51:1319-1329.
7. Qureshi AI, Ali Z, Suri MF, Kim SH, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49:41-50.
8. Qureshi AI, Suri MF, Shatla AA, et al. Intra-arterial recombinant tissue plasminogen activator for ischemic stroke: an accelerating dosing regimen. Neurosurgery 2000;47:473-479.
9. Huet H, Leroy G, Toulas P, Coskun O, Theron J. Radiological confirmation of brain death: digitized cerebral parenchymography. Preliminary report. Neuroradiology 1996;38:S42-S46.
10. Qureshi AI, Siddiqui AM, Kim SH, et al. Rapid angiographic assessment of cerebral perfusion in patients with acute ischemic stroke undergoing intra-arterial thrombolysis. Paper presented at: Joint Annual Meeting of the AANS/CNS Section on Cerebrovascular Surgery & American Society of Interventional and Therapeutic Neuroradiology; February 16-19, 2003; Phoenix, AZ.
11. Rankin J. Cerebral vascular accidents in patients over the age of 60, II: Prognosis. Scott Med J 1957;2:200-15.
12. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
13. Wolfe CD, Taub NA, Woodrow EJ, Burney PG. Assessment of scales of disability and handicap for stroke patients. Stroke 1991;22:1242-1244.
14. Jones T, Morawetz R, Crowell R, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54:773-782.
15. Fisher M, Garcia J. Evolving stroke and the ischemic penumbra. Neurology 1996;47:884-888.
16. Ueda T, Sakaki S, Yuh WT, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metal 1999;19:99-108.
17. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
18. Warach S. New imaging strategies for patient selection for thrombolytic and neuroprotective therapies. Neurology 2001;57:S48-S52.
19. Darby DG, Barber PA, Gerraty RP, et al. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999;30:2043-2052.
20. Marks MP, Tong DC, Beaulieu C, Albers GW, de Crespigny A, Moseley ME. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 1999;52:1792-1798.
21. Schellinger PD, Jansen O, Fiebach JB, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000;31:1318-1328.
22. Gerraty RP, Parsons MW, Barber PA, et al. Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging. Stroke 2002;33:2019-2024.
23. The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 2000;31:601-609.
24. Krieger DW, De Georgia MA, Abou-Chebl A, Andrefsky JC, Sila CA, Katzan IL, Mayberg MR, Furlan AJ. Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke 2001;32:1847-1854.
25. Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno F, Koroshetz WJ. Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997;28:2133-2138.